alpha-Adrenergic Blocker class drugs

12 results
Northwind Pharmaceuticals
Usage: Please provide the specific drug name or information you would like summarized, and I'll be happy to help!
Zydus Lifesciences Limited
Zydus Lifesciences Limited
Zydus Lifesciences Limited
Novitium Pharma LLC
Usage: Phenoxybenzamine Hydrochloride Capsules are indicated for treating pheochromocytoma, specifically to manage hypertension and sweating episodes. If tachycardia occurs excessively, a beta-blocking agent may be needed alongside.
Precision Dose Inc.
Usage: Phentolamine Mesylate for Injection is indicated for preventing or controlling hypertensive episodes in pheochromocytoma, treating dermal necrosis from norepinephrine extravasation, and diagnosing pheochromocytoma via the blocking test.
Lannett Company, Inc.
Usage: Prazosin hydrochloride is indicated for hypertension treatment to lower blood pressure, thus reducing the risk of cardiovascular events such as strokes and myocardial infarctions. It may be used alone or with other antihypertensive agents as part of comprehensive cardiovascular risk management.
Prasco Laboratories
Usage: Prazosin hydrochloride is indicated for treating hypertension to lower blood pressure, which reduces the risk of cardiovascular events like strokes and heart attacks. It can be used alone or with other antihypertensives, as part of comprehensive cardiovascular risk management.
REMEDYREPACK INC.
Usage: Prazosin hydrochloride capsules are indicated for treating hypertension to lower blood pressure, thereby reducing the risk of cardiovascular events like strokes and myocardial infarctions. It can be used alone or with other antihypertensive medications as part of comprehensive cardiovascular risk management.
Novitium Pharma LLC
Usage: Prazosin Hydrochloride Capsules are indicated for treating hypertension, effectively lowering blood pressure to reduce the risk of cardiovascular events like strokes and myocardial infarctions. It may be used alone or in combination with other antihypertensive medications as part of an overall cardiovascular risk management strategy.